Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
essential phospholipids
- Development stage
- Unknown
- Lead developer
- Shayana Farm
- Modality
- Small Molecules
- Administration
- Oral, Intravenous
01
Overview
LIVSON is a hepatoprotective pharmaceutical product developed and marketed by Shayana Farm, primarily available in Uzbekistan and Central Asia. Its active ingredient is a complex of essential phospholipids (EPL), specifically phosphatidylcholine derived from soybeans. These phospholipids serve as vital structural components of hepatocyte cell membranes and organelles. LIVSON facilitates the regeneration of damaged liver tissue by integrating into cell membranes, thereby restoring their integrity, regulating permeability, and supporting essential metabolic functions such as oxidative phosphorylation. It is indicated for the treatment of fatty liver degeneration, chronic hepatitis, liver cirrhosis, and toxic liver damage resulting from alcohol, medications, or environmental toxins. The drug is available in both oral suspension and intravenous injection formulations.
- Brand names
- LIVSON
- Other names
- phospholipidsEPL3-sn-phosphatidylcholinephosphatidylcholineessential phospholipids from soybeans
02
Targets
Hepatocyte phospholipid bilayer
Beyond the preview
Go deeper on essential phospholipids.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on essential phospholipids.